Showing results (201-210 of 298) with videos related to
Sort By:
Pageof 30
European Journal of Haematology|February 24, 2015
OCTET-CY: a phase II study to investigate the efficacy of post-transplant cyclophosphamide as sole graft-versus-host prophylaxis after allogeneic peripheral blood stem cell transplantationUdo Holtick, Jens-Markus Chemnitz, Alexander Shimabukuro-Vornhagen, et al.Cancers|February 11, 2023
Poor Mobilizers in Lymphoma but Not Myeloma Patients Had Significantly Poorer Progression-Free Survival after Autologous Stem Cell Transplantation: Results of a Large Retrospective, Single-Center Observational StudyNormann Steiner, Georg Göbel, Leonie Mauser, et al.International Journal of Molecular Sciences|February 15, 2019
Clonal Hematopoiesis with Oncogenic Potential (CHOP): Separation from CHIP and Roads to AMLPeter Valent, Wolfgang Kern, Gregor Hoermann, et al.Scientific Reports|October 14, 2017
Cibinetide dampens innate immune cell functions thus ameliorating the course of experimental colitisManfred Nairz, David Haschka, Stefanie Dichtl, et al.Cancer Research|April 3, 2015
JAK Inhibition Impairs NK Cell Function in Myeloproliferative NeoplasmsKathrin Schönberg, Janna Rudolph, Maria Vonnahme, et al.Nature Communications|April 20, 2018
Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockadeVictoria Klepsch, Natascha Hermann-Kleiter, Patricia Do-Dinh, et al.American Journal of Hematology|September 16, 2020
The prognostic value of additional copies of 1q21 in multiple myeloma depends on the primary genetic eventMaurus Locher, Michael Steurer, Emina Jukic, et al.Genes, Chromosomes & Cancer|December 5, 2020
Clonal dynamics in a composite chronic lymphocytic leukemia and hairy cell leukemia-variantMaurus Locher, Emina Jukic, Jan-Paul Bohn, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|April 19, 2008
T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistanceUlrich Kintscher, Martin Hartge, Katharina Hess, et al.Transplantation and Cellular Therapy|May 15, 2021
Relapse Protection Following Early Cytomegalovirus Reactivation after Hematopoietic Stem Cell Transplantation Is Limited to HLA-C Killer Cell Immunoglobulin-Like Receptor Ligand Homozygous RecipientsAlexander Nikoloudis, Helga Wagner, Sigrid Machherndl-Spandl, et al.Pageof 30